NCT06785545View on ClinicalTrials.gov

Urinary CA19-9 Level in the Differential Diagnosis of Neurogenic and Non-Neurogenic Lower Urinary Tract Dysfunction in Children

NAActive, not recruitingINTERVENTIONAL

Enrollment

100

Participants

Timeline

Start Date

January 1, 2024

Primary Completion Date

November 12, 2024

Study Completion Date

January 30, 2025

Conditions

Lower Urinary Track Symptoms

Interventions

DIAGNOSTIC_TEST

CA19-9

All patients Ca19-9 levels calculated from their urinary samples

Trial Locations (1)

34854

Marmara University School of Medicine Urology Department, Istanbul

Sponsors

Lead Sponsor

Marmara University

All Listed Sponsors

lead

Marmara University

OTHER

NCT06785545 - Urinary CA19-9 Level in the Differential Diagnosis of Neurogenic and Non-Neurogenic Lower Urinary Tract Dysfunction in Children | Biotech Hunter | Biotech Hunter